Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
157.70
-2.11 (-1.32%)
Aug 13, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
| Insurance Carriers | 1.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Insurance Carriers Growth | 47.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Partners | 97.21M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Partners Growth | 7.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patients | 27.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patients Growth | 12.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
| United States | 1.66B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 45.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas, excluding US | 6.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas, excluding US Growth | 20.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe, Middle East, India, Africa | 23.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe, Middle East, India, Africa Growth | 9.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific and Other | 8.66M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific and Other Growth | 32.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
| Tests Processed | 3.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Processed Growth | 12.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Accessioned | 3.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Accessioned Growth | 12.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Reported in Laboratory | 2.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Reported in Laboratory Growth | 12.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Reported | 2.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tests Reported Growth | 12.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|